ASTS
AST SpaceMobile, Inc.
ASTS has the edge over CAN overall, supported by stronger modeled upside.
CAN
Canaan Inc.
CAN has slightly lower modeled downside risk, despite its lower overall score.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CAN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Stable | |
| Strong |
CAN's revenue and balance sheet are currently healthy, and its cash flow is stable, but its profitability is under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
CAN PE Valuation
CAN has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CAN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| Low |
Analysts expect CAN's losses to grow, with revenue declining. However, they disagree widely on these estimates.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
CAN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.45 | +$0.44 |
| Q1 2026 | -$0.34 | +$0.67 |
| Q4 2025 | -$0.48 | +$0.42 |
| Q3 2025 | -$0.67 | +$0.68 |
| Q2 2025 | -$0.89 | +$0.66 |
| Q1 2025 | -$1.01 | +$1.04 |
| Q4 2024 | -$0.90 | +$1.49 |
| Q3 2024 | -$1.35 | +$0.81 |
CAN has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over CAN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
CAN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $31.9M | -68% |
| Q1 2026 | $62.7M | -24% |
| Q4 2025 | $196.3M | +121% |
| Q3 2025 | $150.7M | +105% |
| Q2 2025 | $100.2M | +39% |
| Q1 2025 | $82.8M | +136% |
| Q4 2024 | $88.8M | +81% |
| Q3 2024 | $73.6M | +121% |
CAN's revenue is growing: $32M last quarter, down 68% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -192% | -165 points |
| Q1 2026 | -87% | -42 points |
| Q4 2025 | -7.6% | +55 points |
| Q3 2025 | -15% | +62 points |
| Q2 2025 | -27% | +38 points |
| Q1 2025 | -45% | +148 points |
| Q4 2024 | -63% | +127 points |
| Q3 2024 | -77% | +261 points |
CAN has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
CAN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$325.8M |
| Q3 2025 | $0 | +$60.8M |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$325.8M | -$286M |
| Q3 2024 | -$60.8M | -$60.8M |
CAN has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has the edge over CAN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CAN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.6% | +31.7M shares |
| 1 year | +81% | +323M shares |
| 3 years | +326% | +554M shares |
| 5 years | +314% | +548M shares |
| Available history | +396% | +577M shares |
CAN has 723M diluted shares, up 81% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
CAN hasn't bought back shares in the past year.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CAN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | -1.2x | Net Cash |
| Q3 2022 | -0.8x | Net Cash |
| Q2 2022 | -0.8x | Net Cash |
| Q1 2022 | -1.0x | Net Cash |
| Q4 2021 | -1.3x | Net Cash |
| Q3 2021 | -2.9x | Net Cash |
| Q2 2021 | -54.8x | Net Cash |
CAN has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
CAN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.6 | Neutral |
| Stochastic | 10.0 | Oversold |
CAN's weekly RSI is 33 (neutral) and its Stochastic is 10 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
CAN PE vs Technology Sector
| Metric | CAN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CAN has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over CAN on trend strength, trading above more of its moving averages.
CAN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.25 | 36% below |
| 20 week MA | $0.28 | 43% below |
| 50 week MA | $0.44 | 64% below |
| 100 week MA | $0.78 | 79% below |
| 200 week MA | $1.31 | 88% below |
CAN is in a downtrend: it's below all five of its weekly moving averages, and 88% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS has the edge over CAN on returns for 2026, with the stronger performance.
CAN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.63 | $3.73 | -34% |
| 2021 | $3.73 | $5.45 | +46% |
| 2022 | $5.45 | $2.08 | -62% |
| 2023 | $2.08 | $2.31 | +11% |
| 2024 | $2.31 | $2.23 | -3.5% |
| 2025 | $2.23 | $0.76 | -66% |
| 2026 YTD | $0.76 | $0.16 | -79% |
CAN has finished lower in four of the last six years. It's down 79% so far in 2026.